References
- Sinnett P F, Whyte H M. Lifestyle, health and disease: A comparison between Papua New Guinea and Australia. Med J Aust 1978; 1: 1–5
- King H, Heywood P, Zimmet P, et al. Glucose tolerance in a highland population in Papua New Guinea. Diabetes Res 1984; 1: 45–51
- Gordon T, Castelli W P, Hjortland M C, et al. High density lipoproteins as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977; 62: 707–14
- Gordon T, Castelli W P, Hjortland M C. The prediction of coronary heart disease by high density and other lipoproteins: An historical perspective. Hyperlipidemia – diagnosis and therapy, B Rifkind, R Lecy. Grune & Stratton Inc., New York 1983; 71–8
- Cullen K J, McCall M G, Stenhouse N S, Welborn T A. Some consequences of mass health examination in the Busselton community. Med J Aust 1972; 1: 1357–8
- Masarei J RL, Lynch W J, Robertson K, et al. Levels of cholesterol, triglyceride, high-density lipoprotein cholesterol and apoprotein-HDL in an Australian rural population. Pathology 1981; 13: 725–34
- National Heart Foundation of Australia Risk Factor Prevalence Study. National Heart Foundation of Australia, Canberra 1981, Report No. 1, 1980
- Sacks F M, Castelli W P, Donner A, Kass E H. Plasma lipids in vegetarians and controls. N Engl J Med 1975; 292: 1148–51
- Stamler J. Lifestyles, major risk factors, proof and public policy. Circulation 1978; 58: 3–19
- Maddocks D L, Maddocks I. The health of young adults in a Pari village. Papua New Guinea Med J 1977; 20: 110–6
- Wyatt G B, Griew A R, Martin F IR, Campbell D G. Plasma cholesterol, triglyceride and uric acid in urban and rural communities in Papua New Guinea. Aust NZ J Med 1980; 10: 491–5
- Miller G J, Miller N E. Plasma HDL concentration and development of ischaemic heart disease. Lancet 1975; 1: 16–9
- Schmahl F W, Prickler P, Polter B, et al. Are fasting serum triglyceride concentrations sufficient for determining the risk factor status of hypertriglyceridaemia for atherosclerotic vascular disease?. Vasa 1983; 12: 353–6
- Simons L, Gibson J, Jones A, Bain D. Health status of Seventh Day Adventists. Med J Aust 1979; 2: 148
- Maciejko J J, Holmes D R, Kolte B A, et al. Apoprotein A-I as a marker of angiographically-assessed coronary artery disease. N Engl J Med 1983; 309: 385–9
- Brunzell J D, Sniderman A D, Albers J J, Kwiterovich P O., Jr. Apoprotein B and A-I and coronary artery disease in humans. Arteriosclerosis 1984; 4: 79–83
- Nestel P J, Zimmett P. HDL levels in Pacific Islanders. Atherosclerosis 1981; 40: 257–62
- Nestel P, Ringrose H, Taylor R, et al. High density lipoprotein apoprotein variability in a biracial population. Arteriosclerosis 1983; 3: 132–7
- Lippel K, Tyroler H A, Eder H. Meeting summary: Relationship of hypertriglyceridaemia to atherosclerosis. Arteriosclerosis 1981; 1: 406–17
- Avogaro P, Bittolo-Bon G, Cazzolato G, et al. Plasma levels of apoprotein A-l and apolipoprotein B in human arteriosclerosis. Artery 1978; 4: 385–94
- De Backer G, Rosseneu M, Desylpers J P. Discriminative value of lipids and apoproteins in coronary heart disease. Atherosclerosis 1982; 42: 197–203
- Vander Heiden G L, Barboriak J J, Sasse E A, Yorde D E. Correlation of the extent of coronary occlusion with Apo B levels. Application of a new enzyme immunoassay technique for Apo B. Atherosclerosis 1984; 50: 29–33
- Paffenberger R S., Jr, Hyde R T. Exercise in the prevention of coronary heart disease. Prev Med 1984; 1: 3–22